Nanoparticles deliver the goods.
Stephen D
SD
Skaper
D000818:Animals; D000911:Antibodies, Monoclonal / Q000378:metabolism / Q000493:pharmacokinetics*; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000378:metabolism; D053148:Caspase 3 / Q000378:metabolism / Q000493:pharmacokinetics*; D002536:Cerebral Arteries / Q000187:drug effects / Q000378:metabolism; D048271:Chitosan / Q000378:metabolism / Q000493:pharmacokinetics*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D042783:Endothelial Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D020925:Hypoxia-Ischemia, Brain / Q000188:drug therapy / Q000503:physiopathology; D051379:Mice; D053758:Nanoparticles / Q000737:chemistry / Q000627:therapeutic use*; D009410:Nerve Degeneration / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control; D011990:Receptors, Transferrin / Q000276:immunology*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D011990:Receptors, Transferrin; D048271:Chitosan; C505409:Casp3 protein, mouse; D053148:Caspase 3